Exploring healthcare professionals’ knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey

References

• Hussain R, Hassali MA, Babar ZUD. Medicines safety in the globalized context. Global pharmaceutical policy. Singapore: Springer; 2020. p. 1–28.
   Google Scholar
• Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437–53.
   PubMed Web of Science ®Google Scholar
• Wiholm BE, Olsson S, Moore N, Waller P. Spontaneous reporting systems outside the US. In: Strom BL, editor. Pharmacoepidemiology. 3rd ed. Chichester: Wiley; 2000. pp. 175–92.
   Google Scholar
• Fletcher A. Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. J R Soc Med. 1991;84(6):341–4.
   PubMed Web of Science ®Google Scholar
• van Grootheest K, Olsson S, Couper M, de Jong van den Berg L. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13(7):457–64.
   PubMed Web of Science ®Google Scholar
• Alshami M, Azm M. The need of pharmacovigilance activities in Yemen. Glob J Med Res. 2014;4:8–14.
   Google Scholar
• WHO. The importance of pharmacovigilance—safety monitoring of medicinal products. United Kingdom: World Health Organization; 2002. http://apps.who.int/medicinedocs/en/d/Js4893e/.
   Google Scholar
• Babar ZUD, Francis S. Identifying priority medicines policy issues for New Zealand: a general inductive study. BMJ Open. 2014;4(5):e004415.
   PubMed Web of Science ®Google Scholar
• Kousar R, Murtaza G, Azhar S, Khan SA, Curley L. Randomized controlled trials covering pharmaceutical care and medicines management: a systematic review of literature. Res Social Adm Pharm. 2018;14(6):521–39.
   PubMed Web of Science ®Google Scholar
• Upvall MJ, Karmaliani R, Pirani F , et al. Developing nursing leaders through graduate education in Pakistan. Int J Nurs Educ Scholarsh. 2004;1(Article27).
   Google Scholar
• Wilbur K. Pharmacovigilance in the middle east. Drug Saf. 2013;36(1):25–30.
   PubMed Web of Science ®Google Scholar
• UMC. Members of the WHO Programme for International Drug Monitoring. Geneva: Uppsala Monitoring Centre; 2019. https://www.who-umc.org/global-pharmacovigilance/members/who-programme-members/.
   Google Scholar
• DRAP. Pakistan National Pharmacovigilance Guidelines (Draft). 1st ed. Islamabad: Drug Regulatory Authority of Pakistan; 2019. p. 95.
   Google Scholar
• Hussain R, Hassali MA, Muneswarao J, Atif M, Babar ZUD. A qualitative evaluation of adverse drug reaction reporting system in Pakistan: findings from the nurses’ perspective. Int J Environ Res Public Health. 2020;17(9):3039.
   PubMed Web of Science ®Google Scholar
• Hussain R, Hassali MA, Muneswarao J, Hashmi F. Physicians’ understanding and practices of Pharmacovigilance: qualitative experience from a lower middle-income country. Int J Environ Res Public Health. 2020;17(7):2209.
   PubMed Web of Science ®Google Scholar
• Hussain R, Hassali MA, Hashmi F, Farooqui M. A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan. J Pharm Policy Pract. 2018;11(1):16.
   PubMed Web of Science ®Google Scholar
• Zolezzi M, Parsotam N. Adverse drug reaction reporting in New Zealand: implications for pharmacists. Ther Clin Risk Manag. 2005;1(3):181.
   PubMedGoogle Scholar
• Al Dweik R, Stacey D, Kohen D, Yaya S. Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol. 2017;83(4):875–83.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf. 2013;36(5):317–28.
   PubMed Web of Science ®Google Scholar
• Paudyal V. Behavioral aspects of pharmacovigilance: research methods considerations. Social and administrative aspects of pharmacy in low-and middle-income countries. Elsevier; 2018. p. 163–75.
   Google Scholar
• Hussain R, Hassali MA. Current status and future prospects of pharmacovigilance in Pakistan. J Pharm Policy Pract. 2019;12(1):1–3.
   PubMedGoogle Scholar
• Elfil M, Negida A. Sampling methods in clinical research: an educational review. Emerg (Tehran). 2017;5:e52.
   PubMedGoogle Scholar
• Cochran WG. Sampling techniques. 3rd ed. New York: Wiley; 1977.
   Google Scholar
• Chatterjee S, Lyle N, Ghosh S. A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India. Drug Saf. 2006;29(7):641–2.
   PubMed Web of Science ®Google Scholar
• Ekman E, Bäckström M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol. 2009;65(1):43–6.
   PubMed Web of Science ®Google Scholar
• Fadare JO, Enwere OO, Afolabi AO, Chedi BA, Musa A. Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria. Trop J Pharm Res. 2011;10:235–42.
   Web of Science ®Google Scholar
• Conforti A, Opri S, D’Incau P, Sottosanti L, Moretti U, Ferrazin F, et al. Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database. Pharmacoepidemiol and Drug Saf. 2012;21(6):597–602.
   PubMed Web of Science ®Google Scholar
• De Angelis A, Giusti A, Colaceci S, Vellone E, Alvaro R. Nurses’ reporting of suspect adverse drug reactions: a mixed-methods study. Annali dell’Istituto superiore di sanita. 2015;51:277–83.
   PubMed Web of Science ®Google Scholar
• Almandil NB. Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance. Saudi Med J. 2016;37(12):1359.
   PubMed Web of Science ®Google Scholar
• Alsaleh FM, Alzaid SW, Abahussain EA, Bayoud T, Lemay J. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait. Saudi Pharm J. 2017;25(6):830–7.
   PubMed Web of Science ®Google Scholar
• Adhikari A, Indu R, Ray M, Bhattacharya S, Biswas R, Das AK. Knowledge, attitude and perception of physicians towards adverse drug reaction (ADR) reporting: a pharmacovigilance study. Int J Adv Med. 2017;4(6):1685.
   Google Scholar
• Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc. 1952;47(260):583–621.
   Web of Science ®Google Scholar
• Suyagh M, Farah D, Farha RA. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm J. 2015;23(2):147–53.
   PubMed Web of Science ®Google Scholar
• McLernon DJ, Bond CM, Hannaford PC, Watson MC, Lee AJ, Hazell L, et al. Adverse drug reaction reporting in the UK. Drug Saf. 2010;33(9):775–88.
   PubMed Web of Science ®Google Scholar
• Abdel-Latif MM, Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J. 2015;23(2):154–61.
   PubMed Web of Science ®Google Scholar
• Hussain R, Hassali MA, Babar ZUD. Quantitative methods in pharmacy practice research. In: Babar ZUD, editor. Encyclopedia of pharmacy practice and clinical pharmacy. Elsevier. 2019. pp. 22–8.
   Google Scholar
• Bule MH, Hamido BA, Chala TS, Kefeni GT. Knowledge, attitudes and practices of healthcare professionals towards adverse drug reaction reporting in Adama hospital medical college, east Shoa zone, Oromia regional state, Ethiopia. J Pharm Innov. 2016;5(7, Part A):24.
   Google Scholar
• Shanko H, Abdela J. Knowledge, attitudes, and practices of health care professionals toward adverse drug reaction reporting in Hiwot Fana specialized university Hospital, Harar, eastern Ethiopia: a cross-sectional study. Hosp Pharm. 2018;53(3):177–87.
   PubMed Web of Science ®Google Scholar
• Prakash S, Yadav P, Yadav K. Perspectives of developing nursing education in Nepal. Nurs Care Open Access J. 2018;5(4):214–20.
   Google Scholar
• Santosh K, Tragulpiankit P, Gorsanan S, Edwards IR,. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal. BMC Pharmacol Toxicol. 2013;14(1):16.
   PubMedGoogle Scholar
• Li Q, Zhang S-M, Chen H-T, Fang S-P, Yu X, Liu D, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J. 2004;117(6):856–61.
   PubMed Web of Science ®Google Scholar
• Babar ZUD, Jamshed S. Social pharmacy strengthening clinical pharmacy: why pharmaceutical policy research is needed in Pakistan? Pharm World Sci. 2008;30:617–9. https://doi.org/10.1007/s11096-008-9246-z.
   PubMedGoogle Scholar
• Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf. 2010;19(3):217–22.
   PubMed Web of Science ®Google Scholar
• Scahill SL, Akhlaq M, Garg S. A bibliometric review of pharmacy education literature in the context of low-to middle-income countries. Curr Pharm Teach Learn. 2003;5(3):218–32.
   Google Scholar
• AlShammari TM, Almoslem MJ. Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-centre cross sectional study. Saudi Pharm J. 2018;26(7):925–31.
   PubMed Web of Science ®Google Scholar
• Atif M, Ahmad M, Saleem Q, Curley L, Qamar-uz-Zaman M. Pharmaceutical policy in Pakistan. In: Pharmaceutical policy in countries with developing healthcare systems. Cham: Adis; 2017. p. 25–44.
   Google Scholar
• Alshammari TM, Alamri KK, Ghawa YA, Alohali NF, Abualkol SA, Aljadhey HS. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia. Int J Clin Pharm. 2015;37(6):1104–10.
   PubMed Web of Science ®Google Scholar
• Scahill S, Harrison J, Carswell P, Babar ZUD. Organisational culture: an important concept for pharmacy practice research. Pharm World Sci. 2009;31:517–21. https://doi.org/10.1007/s11096-009-9318-8.
   PubMedGoogle Scholar
• Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62.
   PubMedGoogle Scholar
• Alsaleh F, Lemay J, Al Dhafeeri R, AlAjmi S, Abahussain E, Bayoud T. Adverse drug reaction reporting among physicians working in private and government hospitals in Kuwait. Saudi Pharm J. 2017;25(8):1184–93.
   PubMed Web of Science ®Google Scholar
• Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T. Knowledge of adverse drug reaction reporting among healthcare professionals in Bhutan: a cross-sectional survey. Drug Saf. 2016;39(12):1239–50.
   PubMed Web of Science ®Google Scholar
• Oxford Collaboration, Newton PN, Bond KC, Babar Z. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Glob Health. 2020;8(6):e754–5. https://doi.org/10.1016/S2214-109X(20)30136-4.
   PubMed Web of Science ®Google Scholar
• Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9(1):14.
   PubMedGoogle Scholar
• Bäckström M, Mjörndal T, Dahlqvist R, Nordkvist-Olsson T. Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol. 2000;56(9–10):729–32.
   PubMed Web of Science ®Google Scholar
• Hadi MA, Neoh CF, Zin RM, Elrggal ME, Cheema E. Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract. 2017;6:91.
   PubMed Web of Science ®Google Scholar
• Osemene KP, Ayeni MI, Afolabi MO. The role of community pharmacists in monitoring adverse drug reactions in Nigeria. J Pharm Health Serv Res. 2012;3(4):197–204.
   Google Scholar
• Roberts P, Wolfson D, Booth T.The role of pharmacists in adverse drug reaction reporting. Drug Saf. 1994;11:7–11.
   PubMed Web of Science ®Google Scholar
• Glassman P. Clinical pharmacist’s role in preventing adverse drug events: brief update review. Making health care safer II: an updated critical analysis of the evidence for patient safety practices. 2013.
   Google Scholar
• Calvert R. Clinical pharmacy—a hospital perspective. Br J Clin Pharmacol. 1999;47(3):231.
   PubMed Web of Science ®Google Scholar
• Schlienger RG, Lüscher TF, Haefeli WE, Schoenenberger RA. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;21(3):110–5.
   PubMedGoogle Scholar